These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 18828819)

  • 1. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: radiographic observations.
    Leknes KN; Yang J; Qahash M; Polimeni G; Susin C; Wikesjö UM
    Clin Oral Implants Res; 2008 Oct; 19(10):1027-33. PubMed ID: 18828819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-7 (rhBMP-7/rhOP-1): radiographic observations.
    Leknes KN; Yang J; Qahash M; Polimeni G; Susin C; Wikesjö UM
    J Clin Periodontol; 2008 Oct; 35(10):914-9. PubMed ID: 18727659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations.
    Wikesjö UM; Qahash M; Polimeni G; Susin C; Shanaman RH; Rohrer MD; Wozney JM; Hall J
    J Clin Periodontol; 2008 Nov; 35(11):1001-10. PubMed ID: 18976397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alveolar ridge augmentation using implants coated with recombinant human growth/differentiation factor -5 (rhGDF-5). Radiographic observations.
    Leknes KN; Yang J; Qahash M; Polimeni G; Susin C; Wikesjö UM
    Clin Oral Implants Res; 2013 Nov; 24(11):1185-91. PubMed ID: 22882602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-7 (rhBMP-7/rhOP-1): histological observations.
    Susin C; Qahash M; Polimeni G; Lu PH; Prasad HS; Rohrer MD; Hall J; Wikesjö UM
    J Clin Periodontol; 2010 Jun; 37(6):574-81. PubMed ID: 20345394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alveolar ridge augmentation using anodized implants coated with Escherichia coli-derived recombinant human bone morphogenetic protein 2.
    Huh JB; Park CK; Kim SE; Shim KM; Choi KH; Kim SJ; Shim JS; Shin SW
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jul; 112(1):42-9. PubMed ID: 21194992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alveolar ridge augmentation using implants coated with recombinant human growth/differentiation factor-5: histologic observations.
    Polimeni G; Wikesjö UM; Susin C; Qahash M; Shanaman RH; Prasad HS; Rohrer MD; Hall J
    J Clin Periodontol; 2010 Aug; 37(8):759-68. PubMed ID: 20500538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog.
    Barboza EP; Duarte ME; Geolás L; Sorensen RG; Riedel GE; Wikesjö UM
    J Periodontol; 2000 Mar; 71(3):488-96. PubMed ID: 10776939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of recombinant human bone morphogenetic protein-2 in dehiscence defects with non-submerged immediate implants: an experimental study in Cynomolgus monkeys.
    Hanisch O; Sorensen RG; Kinoshita A; Spiekermann H; Wozney JM; Wikesjö UM
    J Periodontol; 2003 May; 74(5):648-57. PubMed ID: 12816297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of implants coated with recombinant human bone morphogenetic protein-2 and vacuum-dried using the critical-size supraalveolar peri-implant defect model in dogs.
    Decker JF; Lee J; Cortella CA; Polimeni G; Rohrer MD; Wozney JM; Hall J; Susin C; Wikesjö UM
    J Periodontol; 2010 Dec; 81(12):1839-49. PubMed ID: 20629551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Space-providing expanded polytetrafluoroethylene devices define alveolar augmentation at dental implants induced by recombinant human bone morphogenetic protein 2 in an absorbable collagen sponge carrier.
    Wikesjö UM; Qahash M; Thomson RC; Cook AD; Rohrer MD; Wozney JM; Hardwick WR
    Clin Implant Dent Relat Res; 2003; 5(2):112-23. PubMed ID: 14536046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone reconstruction following implantation of rhBMP-2 and guided bone regeneration in canine alveolar ridge defects.
    Jovanovic SA; Hunt DR; Bernard GW; Spiekermann H; Wozney JM; Wikesjö UM
    Clin Oral Implants Res; 2007 Apr; 18(2):224-30. PubMed ID: 17348887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior mandible (Type II bone) in dogs.
    Wikesjö UM; Xiropaidis AV; Qahash M; Lim WH; Sorensen RG; Rohrer MD; Wozney JM; Hall J
    J Clin Periodontol; 2008 Nov; 35(11):985-91. PubMed ID: 18976395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alveolar ridge augmentation with rhBMP-2 and bone-to-implant contact in induced bone.
    Sigurdsson TJ; Nguyen S; Wikesjo UM
    Int J Periodontics Restorative Dent; 2001 Oct; 21(5):461-73. PubMed ID: 11693239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buccal bone formation after flapless extraction: a randomized, controlled clinical trial comparing recombinant human bone morphogenetic protein 2/absorbable collagen carrier and collagen sponge alone.
    Coomes AM; Mealey BL; Huynh-Ba G; Barboza-Arguello C; Moore WS; Cochran DL
    J Periodontol; 2014 Apr; 85(4):525-35. PubMed ID: 23826643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronan supports recombinant human bone morphogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs. A pilot study.
    Hunt DR; Jovanovic SA; Wikesjö UM; Wozney JM; Bernard GW
    J Periodontol; 2001 May; 72(5):651-8. PubMed ID: 11394401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Horizontal ridge augmentation of the atrophic anterior maxilla using rhBMP-2/ACS or autogenous bone grafts: a proof-of-concept randomized clinical trial.
    de Freitas RM; Susin C; Spin-Neto R; Marcantonio C; Wikesjö UM; Pereira LA; Marcantonio E
    J Clin Periodontol; 2013 Oct; 40(10):968-75. PubMed ID: 23998375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The critical-size supraalveolar peri-implant defect model: characteristics and use.
    Wikesjö UM; Susin C; Qahash M; Polimeni G; Leknes KN; Shanaman RH; Prasad HS; Rohrer MD; Hall J
    J Clin Periodontol; 2006 Nov; 33(11):846-54. PubMed ID: 16965525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior maxilla (Type IV bone) in non-human primates.
    Wikesjö UM; Huang YH; Xiropaidis AV; Sorensen RG; Rohrer MD; Prasad HS; Wozney JM; Hall J
    J Clin Periodontol; 2008 Nov; 35(11):992-1000. PubMed ID: 18976396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of implants coated with rhBMP-2 using two different coating strategies: a critical-size supraalveolar peri-implant defect study in dogs.
    Lee J; Decker JF; Polimeni G; Cortella CA; Rohrer MD; Wozney JM; Hall J; Susin C; Wikesjö UM
    J Clin Periodontol; 2010 Jun; 37(6):582-90. PubMed ID: 20345393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.